Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,005 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmaceutical intervention for adverse events improves quality of life in patients with cancer undergoing outpatient chemotherapy.
Fujii H, Ueda Y, Hirose C, Ohata K, Sekiya K, Kitahora M, Sadaka S, Yamamoto S, Watanabe D, Kato-Hayashi H, Iihara H, Kobayashi R, Kaburaki M, Matsuhashi N, Takahashi T, Makiyama A, Yoshida K, Hayashi H, Suzuki A. Fujii H, et al. Among authors: kobayashi r. J Pharm Health Care Sci. 2022 Mar 2;8(1):8. doi: 10.1186/s40780-022-00239-w. J Pharm Health Care Sci. 2022. PMID: 35236407 Free PMC article.
Anorexia, pain and peripheral neuropathy are associated with a decrease in quality of life in patients with advanced pancreatic cancer receiving outpatient chemotherapy - a retrospective observational study.
Fujii H, Koda M, Sadaka S, Ohata K, Kato-Hayashi H, Iihara H, Kobayashi R, Ishihara T, Uemura S, Iwashita T, Hayashi H, Sugiyama T, Shimizu M, Suzuki A. Fujii H, et al. Among authors: kobayashi r. J Pharm Health Care Sci. 2021 Aug 2;7(1):27. doi: 10.1186/s40780-021-00210-1. J Pharm Health Care Sci. 2021. PMID: 34334136 Free PMC article.
Effectiveness of countermeasure for polypharmacy by multidisciplinary team review in patients with diabetes mellitus.
Nishida S, Kato T, Hayashi Y, Yamada S, Fujii H, Yamada M, Asai N, Shimizu S, Niwa T, Iihara H, Kubota S, Sakai M, Takahashi Y, Takao K, Mizuno M, Hirota T, Kobayashi R, Horikawa Y, Yabe D, Suzuki A. Nishida S, et al. Among authors: kobayashi r. J Diabetes Investig. 2023 Oct;14(10):1202-1208. doi: 10.1111/jdi.14046. Epub 2023 Jun 25. J Diabetes Investig. 2023. PMID: 37357565 Free PMC article.
Prophylactic effect of scopolamine butylbromide, a competitive antagonist of muscarinic acetylcholine receptor, on irinotecan-related cholinergic syndrome.
Iihara H, Fujii H, Yoshimi C, Kobayashi R, Matsuhashi N, Takahashi T, Yoshida K, Suzuki A. Iihara H, et al. Among authors: kobayashi r. Cancer Chemother Pharmacol. 2019 Mar;83(3):393-398. doi: 10.1007/s00280-018-3736-z. Epub 2018 Dec 18. Cancer Chemother Pharmacol. 2019. PMID: 30564875 Free PMC article.
2,005 results